A Systematic Review of Tyrosine Kinase Inhibitors as First Line Treatment for Advanced Non Small Cell Lung Cancer
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.285
https://www.valueinhealthjournal.com/article/S1098-3015(16)30865-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2716
First Page :
A885
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30865-8&doi=10.1016/j.jval.2016.08.285